![Erin Mitchell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erin Mitchell
Corporate Officer/Principal chez DNAtrix, Inc.
Postes actifs de Erin Mitchell
Sociétés | Poste | Début | Fin |
---|---|---|---|
DNAtrix, Inc.
![]() DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
Historique de carrière de Erin Mitchell
Anciens postes connus de Erin Mitchell
Sociétés | Poste | Début | Fin |
---|---|---|---|
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formation de Erin Mitchell
McMaster University | Undergraduate Degree |
University of Toronto | Graduate Degree |
University of Cambridge | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Canada | 3 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorielle
Consumer Services | 4 |
Electronic Technology | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
DNAtrix, Inc.
![]() DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Technology |
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Erin Mitchell
- Expérience